Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: Gurupup who wrote (1623)	4/1/1998 10:21:00 AM
From: JanyBlueEyes	Read Replies (1) \| Respond to of 5736

News - 1997 Fiscal Results NEW YORK--(BUSINESS WIRE)--April 1, 1998--Chromatics Color Sciences International Inc. (NASDAQ:CCSI) announced its 1997 fiscal year results today. Revenues for the fiscal year ended December 31, 1997 was $250,400 (a $37,000 decrease from 1996 revenues). Chromatics incurred net losses of $5,303,500 (net loss of $0.40 per share) and $4,442,300 (net loss of $0.51 per share) for the fiscal years 1997 and 1996, respectively. Loss per share for 1997 reflects, and loss per share for 1996 was restated to reflect, the company's 1997 three-for-two stock split. The $610,800 increase in such losses in 1997 as compared to 1996 is primarily attributable to expenses incurred in 1997 in respect of increased patent application costs, write-offs of certain inventory, non-cash expenses relating to the grant of options to consultants and increased research and development expenses. The 1997 loss was mitigated by the capitalization of $124,000 of software development cost, decreased FDA medical application costs and a decrease in other expenses. The Company is engaged in the business of color science......... Certain of the matters discussed in this announcement contain forward-looking statements.........